NOS3 and hyperlipidemia: Therefore, hyperlipidemia, hyperglycaemia and proinflammatory cytokines are known to selectively impair the PI3K/AKT/eNOS pathway, increase oxidative stress and enhance the release of ET-1 by intact or heightened MAPK-ET-1 pathway from the endothelium [32].